All In Biotech

Free tool

FAERS Monitor: Restoril

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018163 or its brand name (Restoril, Temazepam). Reports on generic versions are filed under their own applications.

Reports

37,909

Serious

28,415

75% of reports

Hospitalization

12,655

Death reported

7,674

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue2,856
  • drug ineffective2,480
  • nausea2,454
  • pain2,332
  • headache2,331
  • toxicity to various agents2,306
  • diarrhoea1,841
  • dyspnoea1,792
  • insomnia1,707
  • death1,701
  • dizziness1,691
  • off label use1,683
  • fall1,667
  • anxiety1,532
  • asthenia1,466

Reports by year received

View as table
YearReports
2004841
2005965
20061,079
2007922
2008924
20091,231
20101,588
20111,536
20121,790
20131,473
20141,664
20152,614
20162,850
20172,573
20182,626
20192,570
20202,378
20211,862
20221,352
20231,427
20241,528
20251,173
2026941

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,016,250 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
toxicity to various agentsSignal2,3067.77.413,311
insomniaSignal1,7073.63.43,179
anxietySignal1,5323.02.92,054
fallSignal1,6672.82.71,931
astheniaSignal1,4662.22.1934
painSignal2,3322.12.01,397
headacheSignal2,3312.12.01,317
fatigueSignal2,8562.02.01,564
dizziness1,6911.91.8715
dyspnoea1,7921.81.7600
nausea2,4541.71.7770
diarrhoea1,8411.61.5407
death1,7011.11.015
off label use1,6831.11.07
drug ineffective2,4801.01.05

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.